Impact of smoking on estrogenic efficacy

Climacteric

Volumn 18, Issue 1, 2015, Pages 38-46

  Ruan, X ^a   Mueck, A O ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Estrogen metabolism; Estrogens; Hormone therapy; Smoking

Indexed keywords

ESTROGEN; PLACEBO;

BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; COMPENSATION; ESTROGEN ACTIVITY; HORMONE SUBSTITUTION; HUMAN; LIPID METABOLISM; LIVER CLEARANCE; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; SMOKING; THERAPY; TREATMENT FAILURE; ADVERSE EFFECTS; CONTRAINDICATIONS; ESTROGEN THERAPY; FEMALE; INTRADERMAL DRUG ADMINISTRATION; METABOLISM;

ADMINISTRATION, CUTANEOUS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; SMOKING;

EID: 84921289507     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2014.929106     Document Type: Review

References (79)

1. Hartz AJ, He T. Cohort study of risk factors for breast cancer in postmenopausal women. Epidemiol Health 2013;Apr 30;35:e2013003. doi: 10.4178/epih/e2013003
2. Gao CM, Ding JH, Li SP, et al. Active and passive smoking, and alcohol drinking and breast cancer risk in Chinese women. Asian Pac J Cancer Prev 2013;14:993-6
3. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:312-33
4. Rosenberg L, Boggs DA, Bethea TN, Wise LA, Adams-Campbell LL, Palmer JR. A prospective study of smoking and breast cancer among African women. Cancer Causes Control 2013;24:2207-15
5. Reynolds P. Smoking and breast cancer. J Mammary Gland Biol Neoplasia 2013;18:15-23
6. Luo J, Margolis KL, Wactawski-Wende J, et al. Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study. BMJ 2011;Mar 1, 342:d1016; doi: 10.1136/bmj.d1016
7. Hu FB, Stampfer MJ, Manson JE, et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med 2000;343:530-7
8. Polesel J, Serraino D, Zucchetto A, et al. Cigarette smoking and endometrial cancer risk: the modifying effect of obesity. Eur J Cancer Prev 2009;18:476-81
9. Duskova M, Simunkova K, Hill M, et al. Chronic cigarette smoking alters circulating sex hormones and neuroactive steroids in premenopausal women. Phyiol Res 2012;61:97-111
10. Gu F, Caporaso NE, Schairer C, et al. Urinary concentrations of estrogens and estrogen metabolites and smoking in Caucasian women. Cancer Epidemiol Biomarkers Prev 2013;22:58-68
11. Michnovicz JJ, Hershcopf RJ, Naganuma H, et al. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 1986;315:1305-9
12. Michnovicz JJ, Naganuma H, Hershcopf RJ, et al. Increased urinary catechol estrogen excretion in female smokers. Steroids 1988;52:69-83
13. Cramer DW, Huijuan X. Predicting age at menopause. Maturitas 1996;23:319-26
14. Friedman AJ, Ravnikar VA, Barbieri RI. Serum steroid hormone profiles in postmenopausal smokers and nonsmokers. Fertil Steril 1987;47:398-401
15. Lesko SM, Rosenberg L, Kaufman DW, et al. Cigarette smoking and risk of endometrial cancer. N Engl J Med 1985;313:593-6
16. Zhou B, Yang L, Sun Q, et al. Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med 2008;121:501-8
17. Olsson H, Bladström A, Ingvar C. Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy? Obstet Gynecol 2003;102:565-70
18. Ross RK, Pike MC, Vesey MP. Risk factors for uterine fibroids. Br Med J 1986;293:359-62
19. Cramer DW, Wilson E, Stillman RJ, et al. The relationship of endometriosis to menstrual characteristics, smoking and exercise. JAMA 1986;255:1904-8
20. Bjarnason NH, Jorgensen C, Kremmer H, Alexandersen P, Christiansen C. Smoking reduces breast tenderness during oral estrogen-progestogen therapy. Climacteric 2004,7:390-6
21. Wallwiener C, Wallwiener L-M, Seeger H, Mueck AO, Bitzer J, Wallwiener M. Prevalence of sexual dysfunction and impact of contraception in female German medical students. J Sex Med 2010;7:2139-48
22. Wallwiener M, Wallwiener L-M, Seeger H, Mueck AO, Bitzer J, Wallwiener CW. Effects of sex hormones in oral contraceptives on the female sexual function score: a study in German female medical students. Contraception 2010;82:155-9
23. Cochran CJ, Gallicchio L, Miller SR, Zacur H, Flaws JA. Cigarette smoking, androgen levels, and hot flushes in midlife women. Obstet Gynecol 2008;112:1037-44
24. Thompson PA, Ambrosone C. Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr 2000;27:125-34
25. Saintot M, Malaveille C, Hautefeuille A, Gerber M. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk. Int J Cancer 2003;107:652-7
26. Ishibe N, Hankinson SE, Colditz GA, et al. Cigarette smoking, cytochrome P450 1A1 polymorphism, and breast cancer risk in the Nurses' Health Study. Cancer Res 1998;58:667-71
27. Bjarnason NH, Byrjalsen I, Jorgensen HL, Christiansen C. The influence of smoking on uterine bleeding during sequential oral hormone therapy. Climacteric 2007;10:147-54
28. Bumb RC, McClish DK. Cigarette smoking and urinary incontinence . Am J Obstet Gynecol 1992;167:1213-18
29. Jensen J, Christiansen C. Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy. Am J Obstet Gynecol 1988;159:820-5
30. Bjarnason NH, Jorgensen HL, Christiansen C. Acute and long-term estradiol kinetics in smoking postmenopausal women. Climacteric 2012;15:449-54
31. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentration: an analysis of published data. Br Med J 1989;298:784-8
32. Baron JA, Farahmand BY, Weiderpass E, et al. Cigarette smoking, alcohol consumption, and risk of hip fracture in women. Arch Intern Med 2001;161:983-8
33. Callreus M, McGuigan F, Akesson K. Adverse effects of smoking on peak bone mass may be attenuated by higher body mass index in young female smokers. Calcif Tissue Int 2013;93:517-25
34. Brook JS, Balka EB, Zhang C. The smoking patterns of women in their forties: their relationship to later osteoporosis. Psychol Rep 2012;110:351-62
35. Iqbal J, Sun L, Cao J, et al. Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes. Proc Natl Acad Sci USA 2013;110:11115-20
36. Yoon V, Maalouf NM, Sakhaee K. The effects of smoking on bone metabolism. Osteoporos Int 2012;23:2081-92
37. Jensen J, Christiansen C, Rodbror P. Cigarette smoking, serum estrogen, and bone loss during hormone replacement therapy early after menopause. N Engl J Med 1985;313:973-5
38. Kiel DP, Baron JA, Anderson JJ, et al. Smoking eliminates the protective effect of oral estrogen on the risk for hip fracture among women. Ann Intern Med 1992;116:716-21
39. Komulainen M, Kroeger H, Tuppurainen MT, et al. Oral estradiol - identification of early postmenopausal women with no bone response to HRT. Osteoporos Int 2000;11:211-18
40. Leino A, Impivaara O, Kaitsaari M. Effects of HRT on bone in women smokers and alcohol consumers. J Bone Miner Res 1997;12:S355
41. Valk-de Roo GW, Netelenbos JC, Peters-Muller IRA, et al. Continuously combined hormone replacement therapy and bone turnover: the influence of dydrogesterone dose, smoking and initial degree of bone turnover. Maturitas 1997;28:153-62
42. Cubrilo-Turek M, Stavljenic-Rukavina A, Turek S, et al. The usefulness of biochemical markers in predicting the response of hormone replacement therapy in perimenopausal smoking healthy women. Coll Antropol 1999;23:195-201
43. Modena MG, Sismondi P, Mueck AO, et al.; The TREAT Collaborative Group. New evidence regarding hormone replacement therapies is urgently required. Transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits. Maturitas 2005;52:1-10
44. Girdler SS, Hinderliter AL, West SG, et al. Postmenopausal smokers show reduced hemodynamic benefit from oral hormone replacement. Am J Cardiol 2000;86:590-2
45. Ylikorkala O, Cacciatore B, Paakari I, et al. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane. Fertil Steril 1998;69:883-8
46. Geisler J, Omsjo IH, Helle SI, et al. Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking. J Endocrinol 1999;162:265-70
47. Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med 1985;313:1038-43
48. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiologic studies with 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-59
49. Palmer JR, Rosenberg L. Cigarette smoking and the risk of breast cancer. Epidemiol Rev 1993;15:145-56
50. Khuder SA, Mutgi AB, Nugent S. Smoking and breast cancer: a meta-analysis. Rev Environ Health 2001;16:253-61
51. Reynolds P. Smoking and breast cancer. J Mammary Gland Biol Neoplasia 2013;18:15-23
52. Kuhl H. Breast cancer risk in the WHI study: The problem of obesity. Maturitas 2005;51:83-97
53. Luo J, Horn K, Ockene JK, et al. Interaction between smoking and obesity and the risk of developing breast cancer among postmenopausal women: the Women's Health Initiative observational study. Am J Epidemiol 2011;174:919-28
54. Band PR, Le ND, Fang R, Deschamps M. Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet 2002;360:1044-9
55. Glantz SA, Johnson KC. The Surgeon General report on smoking and health 50 years later: breast cancer and the cost of increasing caution. Cancer Epidemiol Biomarkers Prev 2014;23:37-46
56. WHI Investigators Writing Group. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. JAMA 2003;289:3243-53
57. Manjer J, Johansson R, Lenner P. Smoking is associated with postmenopausal breast cancer in women with high levels of estrogens. Int J Cancer 2004;112:324-8
58. Mueck AO, Ruan X. Benefits and risks during HRT-main safety issue breast cancer. Horm Mol Biol Clin Invest 2011;5:105-16
59. Stanczyk FZ. Editorial. Can the increase in breast cancer observed in the estrogen plus progestin arm of the Women's Health Initiative trial be explained by progesterone receptor membrane component 1? Menopause 2011;18:833-4
60. Neubauer H, Ma Q, Zhou J, et al. Possible role of PGRMC1 in breast cancer development. Climacteric 2013;16:509-13
61. Ruan X, Neubauer H, Yang Y, et al. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells. Climacteric 2012;15:467-72
62. Russo J, Russo IH. The role of the basal stem cell of the human breast in normal development and cancer. Adv Exp Med Biol 2011;720:121-34
63. Di Cello F, Flowers VL, Li H, et al. Cigarette smoke induces epithelial to mesenchymal transition and increases the metastatic ability of breast cancer cells. Mol Cancer 2013;12:90
64. Behera SN, Xian H, Balasubramanian R. Human health risk associated with exposure to toxic elements in mainstream and sidestream cigarette smoke. SciTotal Environ 2014;472:947-56
65. Service RF. New role for estrogen in cancer? Science 1998; 279:1631-3
66. Schneider HPG, Mueck AO, Kuhl H. IARC Monographs on carcinogenicity of combined hormonal contraceptives and menopausal therapy. Climacteric 2005;8:311-16
67. Mueck AO, Seeger H. Breast cancer: are estrogen metabolites carcinogenic? Climacteric 2007;10(Suppl 2):62-5
68. Mueck AO, Seeger H. The World Health Organization defines HRT as carcinogenic - is this plausible? Gynecol Endocrinol 2008;24:129-32
69. Seeger H, Wallwiener D, Krämer E, Mueck AO. Comparison of possible carcinogenic estradiol metabolites: Effects on proliferation, apoptosis and metastasis of human breast cancer cells. Maturitas 2006;54:72-7
70. Berstein LM, Tsyrlina EV, Kolesnik OS, et al. Catecholestrogens excretion in smoking and non-smoking postmenopausal women receiving estrogen replacement therapy. J Steroid Biochem Mol Biol 2000;72:143-7
71. Lippert TH, Seeger H, Mueck AO. Pharmacology and toxicology of different estrogens. Gynecol Endocrinol 2001;15(Suppl 4):26-33
72. Lippert TH, Seeger H, Mueck AO. The impact of estrogen metabolites on carcinogenesis. Steroids 2000;65:357-69
73. Lippert TH, Seeger H, Mueck AO. In Oettel M, Schillinger E, eds. Handbook of Experimental Pharmacology, Vol. 135/I: Estrogens and antiestrogens. Heidelberg, New York: Springer, 1999:243-71
74. Mueck AO, Seeger H, Lippert TH. Estradiol metabolism and malignant disease. Maturitas 2002;43:1-10
75. Lippert TH, Seeger H, Mueck AO. Estrogens and the cardiovascular system: role of estradiol metabolites in hormone replacement therapy. Climacteric 1999;1:296-301
76. Mueck AO, Seeger H. 2-Methoxyestradiol-biology and mechanism of action. Steroids 2010;75:625-31
77. Seeger H. Mueck AO, Lippert TH. Estradiol metabolism during oral and transdermal estradiol replacement therapy in the postmenopause. Horm Metab Res 1998;30:598-601
78. Seeger H, Mueck AO, Lippert TH. Effect of norethisterone acetate on estrogen metabolism in postmenopausal women. Horm Metab Res 2000;32:436-9
79. Mueck AO, Seeger H, Gräser T, Lippert TH. Effect of postmenopausal HRT and of oral contraceptives on estradiol metabolism. Horm Metab Res 2001;33:744-7